Publications by authors named "Elizabeth Clutterbuck"

Claim this Profile
S
Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial.
Brama Hanumunthadu, Tesfaye Demissie, Melanie Greenland, Peter Skidmore, Kiarash Tanha, Elizabeth A Clutterbuck

EBioMedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines.
Ali Amini, Lucy C Garner, Robert H Shaw, Neil Wrigley Kelly, Sandra Adele, Elizabeth A Clutterbuck

Sci Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine.
Daniel O'Connor, Elizabeth A Clutterbuck, Malick M Gibani, Sagida Bibi, Katherine A Sanders

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study.
Shuo Feng, Sagida Bibi, Parvinder K Aley, Federica Cappuccini, Elizabeth A Clutterbuck

J Infect· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens.
Marta Valente Pinto, Alex-Mikael Barkoff, Sagida Bibi, Aapo Knuutila, Johanna Teräsjärvi, Elizabeth Clutterbuck

J Immunol Methods· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.
Alexander Maytum, David Porter, Philip de Whalley, Amber Thompson, Emma Plested, Elizabeth Clutterbuck

Pediatr Infect Dis J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination.
Eve Richardson, Sagida Bibi, Florence McLean, Lisa Schimanski, Pramila Rijal, Elizabeth A Clutterbuck

Front Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.
Eimear Kelly, Melanie Greenland, Philip C S de Whalley, Parvinder K Aley, Emma L Plested, Elizabeth A Clutterbuck

J Infect· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children.
Dmitri Kazmin, Elizabeth A Clutterbuck, Giorgio Napolitani, Amanda L Wilkins, Andrea Tarlton

NPJ Vaccines· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
Robert H Shaw, Melanie Greenland, Arabella S V Stuart, Parvinder K Aley, Nick J Andrews, Elizabeth A Clutterbuck

J Infect· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.
Christina Dold, Leanne Marsay, Nelson Wang, Laura Silva-Reyes, Elizabeth Clutterbuck

Sci Transl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Merryn Voysey, Amy Flaxman, Jeremy Aboagye, Parvinder K Aley, Sandra Belij-Rammerstorfer, Elizabeth A Clutterbuck

Clin Exp Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.
Alexander J Mentzer, Daniel O'Connor, Sagida Bibi, Irina Chelysheva, Elizabeth A Clutterbuck

Nat Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T cell profiles in patients with -methyl-ᴅ-aspartate receptor-antibody encephalitis.
Mildred A Iro, Christine S Rollier, Sarosh R Irani, Manish Sadarangani, Adam Al-Diwani, Elizabeth A Clutterbuck

Encephalitis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.
Robert H Shaw, Xinxue Liu, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Elizabeth A Clutterbuck

Lancet Respir Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.
Christine S Rollier, Christina Dold, Luke Blackwell, Aline Linder, Laura Silva-Reyes, Elizabeth Clutterbuck

Vaccine· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
Natalie Gabrielle Marchevsky, Grace Li, Parvinder Aley, Sue Ann Costa Clemens, Jordan Richard Barrett, Elizabeth Clutterbuck

EBioMedicine· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.
Pauline Versteegen, Alex-Mikael Barkoff, Marta Valente Pinto, Jan van de Kasteele, Aapo Knuutila, Elizabeth A Clutterbuck

Front Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
Grace Li, Federica Cappuccini, Natalie G Marchevsky, Parvinder K Aley, Robert Aley, Elizabeth Clutterbuck

Lancet· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Adriana Tomic, Donal T Skelly, Ane Ogbe, Daniel O'Connor, Matthew Pace, Elizabeth A Clutterbuck

Nat Commun· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Arabella S V Stuart, Robert H Shaw, Xinxue Liu, Melanie Greenland, Parvinder K Aley, Elizabeth A Clutterbuck

Lancet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Xinxue Liu, Robert H Shaw, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Elizabeth A Clutterbuck

Lancet· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Amy Flaxman, Natalie G Marchevsky, Daniel Jenkin, Jeremy Aboagye, Parvinder K Aley, Elizabeth A Clutterbuck

Lancet· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
Chang Liu, Helen M Ginn, Wanwisa Dejnirattisai, Piyada Supasa, Beibei Wang, Elizabeth Clutterbuck

Cell· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Katie J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer, Hannah Sharpe, Rebecca Makinson, Elizabeth A Clutterbuck

Nat Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis